Document and Entity Information
Document and Entity Information | Jul. 29, 2024 |
Document And Entity Information [Line Items] | |
Document Type | 8-K |
Document Period End Date | Jul. 29, 2024 |
Entity Registrant Name | NewAmsterdam Pharma Company N.V. |
Entity Incorporation State Country Code | P7 |
Entity File Number | 001-41562 |
Entity Tax Identification Number | 00-0000000 |
Entity Address Address Line 1 | Gooimeer 2-35 |
Entity Address City Or Town | Naarden |
Entity Address Country | NL |
Entity Address Postal Zip Code | 1411 DC |
Country Region | 31 |
City Area Code | (0) 35 |
Local Phone Number | 206 2971 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Amendment Flag | false |
Entity Central Index Key | 0001936258 |
Common Stock [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Ordinary Shares, nominal value €0.12 per share |
Trading Symbol | NAMS |
Security Exchange Name | NASDAQ |
Warrant [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Warrants to purchase Ordinary Shares |
Trading Symbol | NAMSW |
Security Exchange Name | NASDAQ |